Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation

Genes and Development

Volumn 10, Issue 16, 1996, Pages 1979-1990

  Clurman, Bruce E ^a,b   Sheaff, Robert J ^a   Thress, Kenneth ^a   Groudine, Mark ^a,c   Roberts, James M ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

cdk; Cyclin; proteasome; ubiquitin

Indexed keywords

CYCLINE; PROTEASOME; UBIQUITIN;

ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PERIODICITY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; TRANSCRIPTION REGULATION;

ANIMALIA; MAMMALIA;

EID: 0029957947     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.16.1979     Document Type: Article

References (43)

1. 1 cyclin turnover and nutrient uptake are controlled by a common pathway in yeast. Genes & Dev. 9: 399-409.
2. Chen, Z., J. Hagler, V. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitm-proteasome pathway. 1995. Genes & Dev. 9: 1586-1597.
3. Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79: 13-21.
4. Coats, S., M. Flanagan, J. Nourse, and J. Roberts. 1996. Requirement of p27kip1 for restriction point control of the fibroblast cell cycle. Science 272: 877-880.
5. Cross, F. and C. Blake. 1993. The yeast cln3 protein is an unstable activator of cdc28. Mol. Cell. Biol.. 13: 3266-3271.
6. DeGregori, J., T. Kowalik, and J.R. Nevins. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol.. 15: 4215-4224.
7. Deshaies, R. 1995. Make it or break it: The role of ubiquitin-dependent proteolyisis in cellular regulation. Trends Cell Biol.. 5: 428-434.
8. Deshaies, R., V. Chau, and M. Kirschner. 1995. Ubiquitination of the G1 cyclin Cln2p by a cdc34p-dependent pathway. EMBO J.. 14: 303-312.
9. Dulic, V., E. Lees, and S. Reed. 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958-1961.
10. Duronio, R. and P. O'Farrell. 1995. Developmental control of the G1 to S transition in Drosophila: Cyclin E is a limiting downstream target of E2F.. 1995. Genes & Dev.. 9: 1456-1468
11. Geng, Y., E. Eaton, M. Picon, J. Roberts, A. Lundberg, A. Gifford, C. Sardet, and R. Weinberg. 1996. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12: 1173-1179.
12. Glotzer, M., A. Murray, and M. Kirschner. 1991. Cyclin is degraded by the ubiquitin pathway. Nature 349: 132-138.
13. Hochstrasser, M. 1995. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol.. 7: 215-223.
14. Jeffrey, P., A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massague, and N. Pavletich. 1995. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376: 313-320.
15. Jentsch, S. and S. Schlenker. 1995. Selective protein degradation: A journey's end within the proteasome. Cell 82: 881-884.
16. King, R., J. Peters, S. Tugendreich, M. Rolfe, P. Hieter, and M. Kirschener. 1995. A 20S complex containing cdc27 and cdc 16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B. Cell 81: 279-288.
17. Kobayashi, H., E. Stewart, R. Poon, J. Adamczewski, J. Cannon, and T. Hunt. 1992. Identification of the domains in cyclin A required for binding to, and activation of p34cdc2 and p32cdk2 protein kinase subunits. Mol. Biol. Cell 3: 1279-1294.
18. Koff, A., F. Cross, A. Fisher, J. Schumacher, K. Leguellec, M. Philippe, and J.M. Roberts. 1991. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66: 1217-1228.
19. Koff, A., A. Giordano, D. Desai, K. Yamashita, J.W. Harper, S. Elledge, T. Nishimoto, D. Morgon, B.R. Franza, and J.M. Roberts. 1992. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257: 1689-1693.
20. Kulka, R., B. Raboy, R. Schuster, H. Parag, G. Diamond, A. Ciechanover, and M. Marcus. 1988. A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1. J. Biol. Chem.. 263: 15726-15731.
21. Kunkel, T. A., J. Roberts, and R. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Meth. Enzymol.. 154: 367-382.
22. Lanker, S., M. Valdivieso, and C. Wittenberg. 1996. Rapid degradation of the G1 cyclin cln2 induced by CDK-dependent phosphorylation.. 1996. Science 271: 1597-1601.
23. Lew, D.J., V. Dulic, and S.I. Reed. 1991. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66: 1197-1206.
24. Nasmyth, K. and L. Dirick. 1991. The role of SW14 and SW16 in the activity of G1 cyclins in yeast. Cell 66: 995-1013.
25. Ogas, J., B.J. Andrews, and I. Herskowitz. 1991. Transcriptional activation of CLN1, CLN2, and a putative new G1 cyclin by SWI4, a positive regulator of G1-specific transcription. Cell 66: 1015-1026.
26. Ohtsubo, M. and J. Roberts. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259: 1908-1912.
27. Ohtsubo, M., A.M. Theodoras, J. Schumacher, J.M. Roberts, and M. Pagano. 1995. Human cyclin E, a nuclear protein essential for the G1 to S phase transition. Mol. Cell. Biol.. 15(5): 2612-2524.
28. Polyak, K., M. Lee, H. Erdjument-Bromage, A. Koff, J. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
29. Resnitzky, D., M. Gossen, H. Bujard, and S. Reed. 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol.. 14: 1669-1679.
30. Rock, K., C. Gram, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771.
31. Rogers, S., R. Wells, and M. Rechsreiner. 1986. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis. Science 234: 364-368.
32. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Assay for β-galactosidase in extracts of mammalian cells. In Molecular Cloning, pp.. 16.66-16.67. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Schneider, B., Y. Yang, and B. Futcher. 1996. Linkage of replication to start by the CDK inhibitor sicl. Science 272: 560-562.
34. Sherr, C. 1994. G1 phase progression: Cycling on cue. Cell 79: 551-555.
35. 1 cyclin-dependent kinases. Genes & Dev.. 9: 1149-1163.
36. Stewart, E., H. Kobayashi, D. Harrison, and T. Hunt. 1994. Destruction of Xenopus cyclins A and B2, but not B1, requires binding to p34cdc2. EMBO J.. 13: 584-594.
37. Sudakin, V., D. Ganoth, A. Dahan, H. Heller, J. Hershko F. Luca, J. Ruderman, and A. Hershko. 1995. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol. Biol. Cell 6: 185-197.
38. Treier, M., L. Staszewski, and D. Bohmann. 1994. Ubiquitin-dependent c-[un degradation in vivo is mediated by the γ domain. Cell 78: 787-798.
39. Tyers, M., G. Tokiwa, R. Nash, and B. Futcher. 1992. The cln2-cdc28 kinase complex of S. cerevisiae is regulated by prote- olysis and phosphorylation. EMBO J.. 11: 1773-1784.
40. van den Heuval, S. and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054.
41. van der Velden, H. and V. Lohka. 1994. Cell cycle-regulated degradation of xenopus cyclin B2 requires binding to p34cdc2. Mol. Cell. Biol.. 5: 713-724.
42. Won, K. and S. Reed. 1996. Activation of cyclin E/cdk2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J.. 15 (in press).
43. cdc28-mediated control of cln3 degradation. Mol. Cell. Biol.. 15: 731-741.